BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 6184570)

  • 1. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Balasubramanian V; Raftery EB
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():113-21. PubMed ID: 6956472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study.
    Gould BA; Hornung RS; Mann S; Subramanian VB; Raftery EB
    Hypertension; 1983; 5(4 Pt 2):II91-6. PubMed ID: 6862589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Acta Med Scand Suppl; 1984; 681():117-23. PubMed ID: 6587750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil compared with nifedipine in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S363-8. PubMed ID: 6184569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.
    Jones RI; Hornung RS; Sonecha T; Raftery EB
    J Hypertens; 1983 Jun; 1(1):85-9. PubMed ID: 6681029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists in the treatment of arterial hypertension].
    Raczka A
    Pol Tyg Lek; 1983 Jan; 38(3):95-7. PubMed ID: 6866828
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists in the treatment of arterial hypertension].
    Chlewicka I; Wasowska T
    Pol Tyg Lek; 1982 Nov; 37(44):1327-9. PubMed ID: 6761674
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled study on the treatment of hypertension with verapamil in retard form].
    Belz GG; Spies G
    Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term management of hypertension with verapamil.
    Lewis GR
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():107-12. PubMed ID: 6811175
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute effects of nifedipine and verapamil on arterial pressure, at rest and during and after exercise in hypertensive patients].
    Novo S; Riolo F; Pinto A; Davì G; Botindari C
    Boll Soc Ital Cardiol; 1980; 25(2):157-63. PubMed ID: 7236440
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.